Annual Cash & Cash Equivalents
$60.20 K
-$25.10 K-29.43%
31 December 2023
Summary:
ABVC BioPharma annual cash & cash equivalents is currently $60.20 thousand, with the most recent change of -$25.10 thousand (-29.43%) on 31 December 2023. During the last 3 years, it has fallen by -$4.21 million (-98.59%). ABVC annual cash & cash equivalents is now -98.97% below its all-time high of $5.83 million, reached on 31 December 2021.ABVC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$137.30 K
+$13.00 K+10.46%
30 September 2024
Summary:
ABVC BioPharma quarterly cash and cash equivalents is currently $137.30 thousand, with the most recent change of +$13.00 thousand (+10.46%) on 30 September 2024. Over the past year, it has dropped by -$362.80 thousand (-72.55%). ABVC quarterly cash and cash equivalents is now -97.64% below its all-time high of $5.83 million, reached on 31 December 2021.ABVC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABVC Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.4% | -72.5% |
| 3 y3 years | -98.6% | -96.3% |
| 5 y5 years | +50.5% | -86.7% |
ABVC Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -99.0% | at low | -97.6% | +350.2% |
| 5 y | 5 years | -99.0% | +50.5% | -97.6% | +350.2% |
| alltime | all time | -99.0% | -97.6% |
ABVC BioPharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $137.30 K(+10.5%) |
| June 2024 | - | $124.30 K(+307.5%) |
| Mar 2024 | - | $30.50 K(-49.3%) |
| Dec 2023 | $60.20 K(-29.4%) | $60.20 K(-88.0%) |
| Sept 2023 | - | $500.10 K(+403.6%) |
| June 2023 | - | $99.30 K(-91.3%) |
| Mar 2023 | - | $1.14 M(+1230.6%) |
| Dec 2022 | $85.30 K(-98.5%) | $85.30 K(-93.6%) |
| Sept 2022 | - | $1.32 M(-54.5%) |
| June 2022 | - | $2.91 M(+7.1%) |
| Mar 2022 | - | $2.72 M(-53.4%) |
| Dec 2021 | $5.83 M(+36.4%) | $5.83 M(+56.9%) |
| Sept 2021 | - | $3.72 M(+301.8%) |
| June 2021 | - | $924.80 K(-64.6%) |
| Mar 2021 | - | $2.62 M(-38.8%) |
| Dec 2020 | $4.27 M(+2861.3%) | $4.27 M(+3049.0%) |
| Sept 2020 | - | $135.70 K(-65.2%) |
| June 2020 | - | $390.20 K(+215.7%) |
| Mar 2020 | - | $123.60 K(-14.3%) |
| Dec 2019 | $144.30 K(+260.8%) | $144.30 K(-86.1%) |
| Sept 2019 | - | $1.04 M(+91.7%) |
| June 2019 | - | $540.30 K(-44.9%) |
| Mar 2019 | - | $981.30 K(+2353.3%) |
| Dec 2018 | $40.00 K(-57.1%) | $40.00 K(+809.1%) |
| Sept 2018 | - | $4400.00(-92.3%) |
| June 2018 | - | $57.40 K(+907.0%) |
| Mar 2018 | - | $5700.00(-93.9%) |
| Dec 2017 | $93.30 K(-54.5%) | $93.30 K(-54.5%) |
| Sept 2017 | - | $204.90 K(+2429.6%) |
| Sept 2017 | $204.90 K(+18.1%) | - |
| June 2017 | - | $8100.00(-92.4%) |
| Mar 2017 | - | $106.40 K(+472.0%) |
| Dec 2016 | - | $18.60 K(-89.3%) |
| Sept 2016 | $173.50 K(-82.6%) | $173.50 K(+104.4%) |
| June 2016 | - | $84.90 K(-90.3%) |
| Mar 2016 | - | $872.60 K(>+9900.0%) |
| Dec 2015 | - | $0.00(-100.0%) |
| Sept 2015 | $994.80 K(>+9900.0%) | $994.80 K(>+9900.0%) |
| June 2015 | - | $2300.00(>+9900.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2014 | - | $500.00(-16.7%) |
| Mar 2014 | - | $600.00(0.0%) |
| Dec 2013 | - | $600.00(0.0%) |
| Sept 2013 | $600.00(-95.5%) | $600.00(0.0%) |
| June 2013 | - | $600.00(-25.0%) |
| Mar 2013 | - | $800.00(-60.0%) |
| Dec 2012 | - | $2000.00(-85.1%) |
| Sept 2012 | $13.40 K(-81.3%) | $13.40 K(-78.7%) |
| June 2012 | - | $62.90 K(>+9900.0%) |
| Mar 2012 | - | $0.00(-100.0%) |
| Dec 2011 | - | $30.20 K(-57.9%) |
| Sept 2011 | $71.80 K(+2464.3%) | $71.80 K(-2.0%) |
| June 2011 | - | $73.30 K(+153.6%) |
| Mar 2011 | - | $28.90 K(+43.1%) |
| Dec 2010 | - | $20.20 K(+621.4%) |
| Sept 2010 | $2800.00(>+9900.0%) | $2800.00(-80.0%) |
| June 2010 | - | $14.00 K(-48.7%) |
| Dec 2009 | - | $27.30 K(>+9900.0%) |
| Sept 2009 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2009 | - | $4300.00(-12.2%) |
| Mar 2009 | - | $4900.00(-99.5%) |
| Sept 2008 | $974.30 K(+20.6%) | $974.30 K(+3482.0%) |
| June 2008 | - | $27.20 K(-85.5%) |
| Mar 2008 | - | $187.50 K(+78.1%) |
| Dec 2007 | - | $105.30 K(-7.6%) |
| Sept 2007 | $808.20 K(+820.5%) | - |
| June 2007 | - | $114.00 K(-13.0%) |
| Mar 2007 | - | $131.00 K(+49.2%) |
| Dec 2006 | $87.80 K(+38.5%) | $87.80 K(+73.2%) |
| Sept 2006 | - | $50.70 K(-0.8%) |
| June 2006 | - | $51.10 K(-14.7%) |
| Mar 2006 | - | $59.90 K(-5.5%) |
| Dec 2005 | $63.40 K(-22.5%) | $63.40 K(-7.3%) |
| Sept 2005 | - | $68.40 K(-10.0%) |
| June 2005 | - | $76.00 K(-7.1%) |
| Mar 2005 | - | $81.80 K(0.0%) |
| Dec 2004 | $81.80 K(-21.9%) | $81.80 K(+69.4%) |
| Sept 2004 | - | $48.30 K(-27.1%) |
| June 2004 | - | $66.30 K(-14.0%) |
| Mar 2004 | - | $77.10 K |
| Dec 2003 | $104.80 K | - |
FAQ
- What is ABVC BioPharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ABVC BioPharma?
- What is ABVC BioPharma annual cash & cash equivalents year-on-year change?
- What is ABVC BioPharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ABVC BioPharma?
- What is ABVC BioPharma quarterly cash and cash equivalents year-on-year change?
What is ABVC BioPharma annual cash & cash equivalents?
The current annual cash & cash equivalents of ABVC is $60.20 K
What is the all time high annual cash & cash equivalents for ABVC BioPharma?
ABVC BioPharma all-time high annual cash & cash equivalents is $5.83 M
What is ABVC BioPharma annual cash & cash equivalents year-on-year change?
Over the past year, ABVC annual cash & cash equivalents has changed by -$25.10 K (-29.43%)
What is ABVC BioPharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ABVC is $137.30 K
What is the all time high quarterly cash and cash equivalents for ABVC BioPharma?
ABVC BioPharma all-time high quarterly cash and cash equivalents is $5.83 M
What is ABVC BioPharma quarterly cash and cash equivalents year-on-year change?
Over the past year, ABVC quarterly cash and cash equivalents has changed by -$362.80 K (-72.55%)